{
  "ptid_time": "109_S_0876_2006-09-19",
  "img_path": "/data/qiuhui/data/adni/images/109_S_0876/2006-09-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 32,593 mm³, 16.1% above the reference mean. With a Z-score of 0.37 (64.4th percentile), this represents normal volume ; hippocampal volume measures 5,264 mm³, 26.0% below the reference mean. With a Z-score of -2.39 (0.9th percentile), this represents significant atrophy; whole brain volume measures 746,249 mm³, 23.4% below the reference mean. With a Z-score of -2.95 (0.2th percentile), this represents significant atrophy; entorhinal cortex volume measures 3,294 mm³, 10.3% below the reference mean. With a Z-score of -0.63 (26.3th percentile), this represents normal volume ; fusiform gyrus volume measures 12,493 mm³, 26.6% below the reference mean. With a Z-score of -2.42 (0.8th percentile), this represents significant atrophy; middle temporal gyrus volume measures 12,818 mm³, 33.1% below the reference mean. With a Z-score of -2.88 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 76.1 years. Gender is Female. Education: 16 years. Handedness: Right. Race: Black or African American. Medical history: Respiratory; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 30.0. Logical Memory: 11.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 529.30 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus, whole brain, fusiform gyrus, and middle temporal gyrus—key regions affected in Alzheimer’s disease (AD). However, the MMSE score of 30 is normal, and Aβ levels are only mildly reduced, which is atypical for AD. The absence of APOE4 also reduces AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting biomarkers—severe atrophy but normal cognition and only mildly reduced Aβ).  \n\n*Note:* If cognitive symptoms develop later, progression to dementia (likely AD) would be expected given the atrophy pattern. A follow-up clinical assessment for subtle cognitive changes is recommended.",
  "timestamp": "2025-07-26T11:27:49.259074"
}